R-Butin (Rifabutin Capsule) 150 mg

R-Butin (Rifabutin) 150 mg capsules are used for tuberculosis prevention and treatment. This antibiotic helps stop bacterial growth in the body. Store below 25°C and keep out of reach of children. Always follow your healthcare provider's guidance.

Strength

150 mg

Pack Size

100s

Storage

Below 25°C

Manufacturer / TM Owner

Jackson Laboratories Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

R-Butin (Rifabutin) 150 mg capsules are prescribed to prevent and treat tuberculosis, particularly in patients with HIV. It may also be used for other bacterial infections as directed by a doctor. This medication works by stopping the growth of bacteria. It does not treat viral infections like the common cold.

Side Effects

R-Butin (Rifabutin) 150 mg capsules may cause mild side effects such as nausea, headache, or discolored urine. Some users report fatigue or joint pain. These effects are usually temporary and should be discussed with a healthcare provider if they persist. Always take as prescribed for best results.

Precautions & Warnings

Store R-Butin (Rifabutin) 150 mg capsules below 25°C in a dry place away from moisture. Keep the container tightly closed when not in use. Avoid exposure to direct sunlight. Do not use if the capsule is damaged or expired. Consult a healthcare provider before starting or stopping this medication.

Avoid Interactions

R-Butin (Rifabutin) 150 mg may interact with certain medications, including blood thinners, antifungals, and HIV treatments. Avoid alcohol while taking this medication as it may increase side effects. Always inform your doctor about all medications and supplements you are using. Some interactions may reduce effectiveness.

References

Frequently Asked Questions

R-Butin (Rifabutin) 150 mg capsules are primarily used to prevent and treat tuberculosis, especially in patients with HIV.

Store R-Butin (Rifabutin) 150 mg capsules below 25°C in a dry, cool place away from moisture and sunlight.

Consult your doctor before taking R-Butin with other medications, as it may interact with certain drugs like blood thinners or HIV treatments.

Common side effects may include nausea, headache, fatigue, or discolored urine. These are usually mild and temporary.

Always consult a healthcare provider before using R-Butin during pregnancy or while breastfeeding.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.